![](https://mdgroup.com/wp-content/uploads/2024/07/Blog_FDA-Guidance_16Jul24-600x300.jpg)
New FDA Guidance Provides Details on Diversity Action Plans for Clinical Studies
Posted | July 9, 2024FDA Guidance Summary The U.S. Food and Drug Administration (FDA) has issued a draft guidance titled “Diversity Action Plans to Improve Enrollment of Participants from Underrepresented Populations in Clinical Studies.”…